IL91369A - Subunit AL-AFL and its history, free from natural contaminants, and pharmaceutical preparations containing it - Google Patents

Subunit AL-AFL and its history, free from natural contaminants, and pharmaceutical preparations containing it

Info

Publication number
IL91369A
IL91369A IL9136989A IL9136989A IL91369A IL 91369 A IL91369 A IL 91369A IL 9136989 A IL9136989 A IL 9136989A IL 9136989 A IL9136989 A IL 9136989A IL 91369 A IL91369 A IL 91369A
Authority
IL
Israel
Prior art keywords
lfa
subunit
alpha
molecule
functional derivative
Prior art date
Application number
IL9136989A
Other languages
English (en)
Hebrew (he)
Other versions
IL91369A0 (en
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL91369A0 publication Critical patent/IL91369A0/xx
Publication of IL91369A publication Critical patent/IL91369A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL9136989A 1988-08-23 1989-08-21 Subunit AL-AFL and its history, free from natural contaminants, and pharmaceutical preparations containing it IL91369A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
IL91369A0 IL91369A0 (en) 1990-04-29
IL91369A true IL91369A (en) 1994-08-26

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9136989A IL91369A (en) 1988-08-23 1989-08-21 Subunit AL-AFL and its history, free from natural contaminants, and pharmaceutical preparations containing it

Country Status (14)

Country Link
EP (1) EP0362526B1 (no)
JP (1) JPH02306999A (no)
KR (1) KR900002796A (no)
AT (1) ATE123810T1 (no)
AU (1) AU634974B2 (no)
DE (1) DE68923048T2 (no)
DK (1) DK412589A (no)
ES (1) ES2075016T3 (no)
FI (1) FI893916A (no)
GR (1) GR3017303T3 (no)
HU (1) HUT53673A (no)
IL (1) IL91369A (no)
NO (1) NO893366L (no)
PT (1) PT91503B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006592A1 (en) * 1987-02-26 1988-09-07 Dana-Farber Cancer Institute, Inc. Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
WO1990010646A1 (en) * 1989-03-09 1990-09-20 Dana Farber Cancer Institute Leukocyte adhesion receptors
CA2050329A1 (en) * 1989-03-09 1990-09-10 Timothy A. Springer Method of treating viral infections using lfa-1
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
DE69131564T2 (de) * 1990-07-20 2000-01-13 Bayer Ag Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
EP0762886A4 (en) * 1994-04-19 1999-03-31 Univ Kansas ICAM-1 / LFA-1 SHORT CHAIN PEPTIDES AND METHODS FOR USE THEREOF
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) * 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
AU4971699A (en) * 1998-07-06 2000-01-24 Bai Luo Hyaluronic acid mimics and methods related thereto
ATE414715T1 (de) * 2003-09-04 2008-12-15 Biomay Ag Hypoallergene polypeptide basierend auf aus fisch gewonnenem parvalbumin
ES2383525T3 (es) 2003-11-05 2012-06-21 Sarcode Bioscience Inc. Moduladores de la adhesión celular
CA2555820C (en) 2004-02-19 2016-01-19 Genentech, Inc. Cdr-repaired antibodies
CA2609053C (en) 2005-05-17 2017-04-25 Sarcode Corporation Compositions and methods for treatment of eye disorders
EP3797775A1 (en) 2007-10-19 2021-03-31 Novartis AG Compositions and methods for treatment of diabetic retinopathy
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
MX2015001098A (es) 2012-07-25 2015-09-25 Sarcode Bioscience Inc Inhibidor del antigeno-1 asociado a la funcion del linfocito (lfa-1) y polimorfo del mismo.

Also Published As

Publication number Publication date
FI893916A (fi) 1990-02-24
DE68923048D1 (de) 1995-07-20
NO893366L (no) 1990-02-26
IL91369A0 (en) 1990-04-29
PT91503B (pt) 1996-04-30
EP0362526A2 (en) 1990-04-11
ATE123810T1 (de) 1995-06-15
JPH02306999A (ja) 1990-12-20
GR3017303T3 (en) 1995-12-31
HUT53673A (en) 1990-11-28
AU4014589A (en) 1990-03-01
ES2075016T3 (es) 1995-10-01
DK412589D0 (da) 1989-08-22
AU634974B2 (en) 1993-03-11
FI893916A0 (fi) 1989-08-21
PT91503A (pt) 1990-03-08
EP0362526A3 (en) 1990-07-18
DK412589A (da) 1990-02-24
DE68923048T2 (de) 1995-11-16
KR900002796A (ko) 1990-03-23
NO893366D0 (no) 1989-08-22
EP0362526B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
EP0362526B1 (en) The Alpha-subunit of the LFA-1 leukocyte adhesion receptor
US5849896A (en) α-subunit of the Mac-1 leukocyte adhesion receptor
RU2130782C1 (ru) Рекомбинантная молекула днк, кодирующая молекулу iсам-3, молекула адгезии iсам-3, антитело, способное связываться с такой молекулой, фармацевтическая композиция
US5919637A (en) Method for identifying reduced binding between GMP-140 and GMP-140 ligand
DK175362B1 (da) Oplöseligt funktionelt derivat af ICAM-1, rekombinant DNA-molekyle og fremgangsmåde til fremstilling af nævnte derivat, farmaceutisk præparat indeholdende et sådant derivat og derivatets anvendelse til fremstilling af et sådant præparat, samt....
IE881322L (en) Intercellular adhesion molecules and their binding ligands
EP0606518B1 (en) Intercellular adhesion molecules and their binding ligands
NZ245651A (en) Ligand molecules (e.g. antibodies and fragments) capable of binding to intercellular adhesion molecule-2 (icam-2) and their use
US6030947A (en) Methods of treating p150,95-mediated inflammation and ICAM-1-mediated viral infection
US5629162A (en) Method of identifying agents which modulate ICAM-3 binding to LFA-1
EP0462205A1 (en) Leukocyte adhesion receptors
LARIGAN et al. Characterization of cDNA and genomic sequences encoding rabbit ELAM-1: conservation of structure and functional interactions with leukocytes
US5877275A (en) Controlling cellular immune/inflammatory responses with β2 integrins
DD297839A5 (de) Alpha-untereinheit des lfa-l-leukozytadhaesionsrezeptors
NZ244853A (en) Antibodies and fragments to icam-1, pharmaceutical composition

Legal Events

Date Code Title Description
RH Patent void